SCHEMBL10153637

SCHEMBL10153637

CC(C)NC(=O)C1C(=O)N(OCc2ccccc2)C(=O)c2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 1/20 0.42
MAPT P10636 2/20 0.40
HSD17B10 Q99714 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
CYP3A4 P08684 4/20 0.39
TSHR P16473 3/20 0.39
PSEN1 P49768 1/20 0.39
PSEN2 P49810 1/20 0.39
APH1B Q8WW43 1/20 0.39
NCSTN Q92542 1/20 0.39
APH1A Q96BI3 1/20 0.39
PSENEN Q9NZ42 1/20 0.39
POLB P06746 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
RAB9A P51151 1/20 0.38
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9959297 0.86 HDAC4 (0.49) KCNA5MAPTMEN1KMT2ATSHR
SCHEMBL9960452 0.84 KCNA5 (0.46) KCNA5MAPTMEN1KMT2A
SCHEMBL9959313 0.84 KCNA5 (0.48) KCNA5MAPTMEN1KMT2APOLB
SCHEMBL9958850 0.84 MEN1 (0.43) KCNA5MAPTHSD17B10MEN1KMT2A
SCHEMBL10153642 0.83 KCNA5 (0.42) KCNA5MAPTMEN1KMT2ATSHR
SCHEMBL11787179 0.83 MEN1 (0.47) MAPTMEN1KMT2ATSHRPOLB
SCHEMBL9958546 0.83 TSHR (0.48) MAPTCYP3A4TSHRALDH1A1CYP2C9
SCHEMBL9958882 0.82 KMT2A (0.46) KCNA5MAPTMEN1KMT2AALDH1A1
SCHEMBL9952002 0.81 MEN1 (0.45) MAPTMEN1KMT2ATSHRPOLB
SCHEMBL9959558 0.81 KCNA5 (0.46) KCNA5MAPTMEN1KMT2ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012085003-A1 2-HYDROXYISOQUINOLINE-1,3(2H,4H)-DIONES AND RELATED COMPOUNDS USEFUL AS HIV REPLICATION INHIBITORS KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) 2012-06-28 WO disclosed